Peer Exchange

  

Updates to the MRI Protocol and Clinical Guidelines for MS: CMSC Working Group


Multiple sclerosis (MS) experts discuss the 2019 Consortium of Multiple Sclerosis Center Annual Meeting, the development of MRI protocol and clinical guidelines, and alignment with the MAGNIMS protocol.

The importance of gadolinium as a contrast agent and central vein sign in scanning and diagnosing multiple sclerosis.

Avoiding misdiagnosis in multiple sclerosis through application of the McDonald criteria and the use of gadolinium.

Panelists discuss leveraging MS treatment decisions based on presence of inflammatory activity.

The consistency and quality of the MRI scanner in detecting new lesions for multiple sclerosis is examined.

A discussion on PML monitoring in multiple sclerosis and approaching modifications to the MAGNIMS guidelines to stay current in clinical practice. The importance of educating the technician on the guidelines is also reviewed.

Optimizing a standardized examination, how MRI should be used in a clinical setting, and the need to be internationally aligned.

Overcoming barriers such as the lack of CMSC protocol use, making it user friendly, and reluctance to change protocols.

Addressing payer-related issues in making the right management decisions to accommodate both the patient and scanner cost.

The importance of a standardized examination, educating payers about how the scan is going to be used, and patients being active in advocating for their care.

Final thoughts on the 2019 CMSC annual meeting and future directions for the procedure for MRI protocols in detecting MS and international alignments.
SAP Partner Banner